between the economic and social/ethical aspects of innovation processes in this field. A key issue of CSR in the innovative …

In the context of the ongoing debate about an innovation crisis in the pharmaceutical industry, we study the success …

Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months) - about 44% of the total increase in longevity … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …

I assess the impact that pharmaceutical innovation had on cancer mortality in Mexico during the period 2003–2013, by ….) that were subject to more pharmaceutical innovation, controlling for changes in the age-standardized cancer incidence rate … of cancer drug innovation to Mexican longevity growth has been valuable, but, perhaps, it could have been even larger …

different configurations of the patent system upon innovation and competition. The model is able to replicate the main stylized … adverse effects in terms of innovation outcomes, as well as of market competition and consumer welfare. Such general …

facilitate follow-on innovation and benefit latecomer firms, especially in the pharmaceutical industry. In this paper, we provide … between firms' innovation and imitation strategies for the design of innovation policies …

largely based on Open Innovation. For that purpose, exploratory case studies will be shown that exemplify the value of … implementing Open Innovation in the pandemic context. These case studies concern the pharmaceutical firm Pfizer, the biotechnology … systematic analysis of articles, scientific documents, and published reports related to the Open Innovation involvement of these …